the three treatment groups , propafenone ( 36 patients ) , lidocaine ( 28 patients ) , and placebo ( 25 patients ) , did not differ with respect to age , gender , prevalence of previous infarction , delay from the onset of pain to hospitalization , clinical features on entry ( the patients with heart failure or malignant arrhythmias were excluded ) , site of acute myocardial infarction , or cpk peak .
C0023660
lidocaine
C0003811
arrhythmias